HOME >> MEDICINE >> NEWS
Landmark study shows coenzyme Q10 slows progressive decline in Parkinsons disease

In the first study of its type, researchers at Emory University and nine other centers nationwide have determined that a naturally occurring compound called coenzyme Q10 can slow progressive deterioration associated with the early stages of Parkinson's disease up to 44 percent. This is the first time a study has shown that any nutrient or vitamin might play a role in slowing the progression of PD. The greatest benefits were seen in motor skills and activities of daily living, such as walking, dressing, feeding and bathing. The results of this study will be published in the Oct. 15 issue of the American Medical Association's Archives of Neurology and will be discussed at the annual meeting of the American Neurological Association in New York City, also on Oct. 15.

"The study was designed to test the hypothesis that high doses of coenzyme Q10 would slow the progression of Parkinson's, as measured by movement difficulty or disability," says Ray Watts, M.D., professor of neurology, Emory University School of Medicine, and lead investigator of the Emory study. "We are very encouraged with the results of this small trial, which consisted of 80 Parkinson's patients nationwide. However, a larger, multi-centered, controlled trial is still needed before this treatment can be recommended to patients with a high degree of certainty."

Parkinson's disease is a progressive disorder of the central nervous system affecting over one million people in the United States. Symptoms include tremor, slowness of movement and stiffness of muscles. Although certain medications, such as levodopa or L-dopa, can reduce the symptoms of PD, they do not slow the progressive deterioration in function.

Scientific evidence shows that mitochondrial function is impaired in Parkinson's disease patients. Mitochondria produce energy for the cells. Research also shows that levels of coenzyme Q10, which the body uses to aid in energy production, are reduced in the mitochondria of P
'"/>

Contact: Janet Christenbury
jmchris@emory.edu
404-727-8599
Emory University Health Sciences Center
14-Oct-2002


Page: 1 2 3

Related medicine news :

1. Landmark survey reveals asthma in children remains significantly out of control in the United States
2. Landmark antidepressant analysis demonstrated significant efficacy of Effexor®/Effexor XR
3. Landmark XENDOS study shows Xenical prevents or delays the development of type 2 diabetes
4. Landmark study demonstrates potential for nerve regeneration treatment of stroke
5. Landmark study results published in NEJM highlight breakthrough treatment for heart failure
6. Landmark study uncovers reasons behind recurring back injury
7. Landmark clinical trial at 22 medical centers finds implanted heart pumps lengthen and improve lives of terminally ill heart failure patients
8. Landmark dialysis study findings could greatly simplify treatment of kidney disease with peritoneal dialysis
9. Landmark school-based social influences smoking-prevention program found not to work
10. U.S., British scientific societies honor penicillin as International Chemical Landmark
11. CODE-2*: Landmark study on the costs of type 2 diabetes in Europe

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/12/2020)... ... January 12, 2020 , ... Cecelia Health ( ... City, has continually innovated for over a decade to transform lives and health ... companies and self-insured employers. By optimizing the mix of expert clinician and digital ...
(Date:1/10/2020)... ... January 10, 2020 , ... WellHaven Pet Health, a family of ... new online community coming in February 2020, LEAD WELL with WOMEN. The community will ... , The vision of LEAD WELL with WOMEN is to empower women, engage all, ...
(Date:1/10/2020)... ... January 10, 2020 , ... ... Oregon, provides a friendly, non-intimidating environment for all women. In search for a ... its current and prospective members. , For nearly 30 years, Balanced Habits, ...
(Date:1/8/2020)... ... January 08, 2020 , ... Mirror ... Magazine’s 2019 Best of Memorial Readers’ Choice Awards. Located adjacent to ... named Best MedSpa in Memorial reflects Mirror Mirror Beauty Boutique’s commitment to the ...
(Date:1/7/2020)... ... January 07, 2020 , ... G-CON Manufacturing, the leader ... company’s 200,000 sq. ft. manufacturing site in College Station, TX. The new facility, ... POD architectural, mechanical, electrical and automation fit out. , “This facility allows us ...
Breaking Medicine News(10 mins):
(Date:1/7/2020)... ... January 07, 2020 , ... Ironsphere, a ... providers, announced today it has been selected by MetLife Stadium for Privileged Access ... “As part of our ongoing commitment to maintain the highest of security policies, ...
(Date:1/5/2020)... ... January 04, 2020 , ... The ... and software firms are fighting for leadership in both devices and voice assistant ... research report, during the past few years, multiple health-related voice assistants have been ...
(Date:1/3/2020)... ... ... Stay on top of current hot topics through free webinars presented by leading experts ... so be sure to register today to save your place. Participate in the discussion ... upcoming webinars: , CLINICAL OPERATIONS , January 23 – The Benefits of a Seamless ...
Breaking Medicine Technology:
Cached News: